ES2035292T3 - Solucion acuosa catartica. - Google Patents

Solucion acuosa catartica.

Info

Publication number
ES2035292T3
ES2035292T3 ES198888305942T ES88305942T ES2035292T3 ES 2035292 T3 ES2035292 T3 ES 2035292T3 ES 198888305942 T ES198888305942 T ES 198888305942T ES 88305942 T ES88305942 T ES 88305942T ES 2035292 T3 ES2035292 T3 ES 2035292T3
Authority
ES
Spain
Prior art keywords
liter
grams
solution
aqueous solution
catartical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888305942T
Other languages
English (en)
Inventor
Herbert G. Hechter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EZ Em Inc
Original Assignee
EZ Em Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EZ Em Inc filed Critical EZ Em Inc
Application granted granted Critical
Publication of ES2035292T3 publication Critical patent/ES2035292T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SE PROPORCIONA UNA DISOLUCION PURGANTE ACUOSA Y METODO PARA LIMPIAR EL INTESTINO. LA DISOLUCION ES ISOTONICA, TIENE UN EFECTO TAMPON MINIMO SOBRE LA SANGRE HUMANA Y ES ESENCIALMENTE INORGANICA. LA DISOLUCION ACUOSA TIENE APROXIMADAMENTE 3,5 G/L DE SULFATO SODICO, 4,82 G/L DE SULFATO MAGNESICO, 1,9 G/L DE BICARBONATO SODICO, 3,85 G/L DE CLORURO SODICO, 0,746 G/L DE CLORURO POTASICO. PARA LIMPIAR EL INTESTINO USUALMENTE SE ADMINISTRAN A UN PACIENTE ENTRE 3,0 Y 4,0 LITROS DE LA DISOLUCION.
ES198888305942T 1987-07-10 1988-06-30 Solucion acuosa catartica. Expired - Lifetime ES2035292T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7186887A 1987-07-10 1987-07-10

Publications (1)

Publication Number Publication Date
ES2035292T3 true ES2035292T3 (es) 1993-04-16

Family

ID=22104118

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888305942T Expired - Lifetime ES2035292T3 (es) 1987-07-10 1988-06-30 Solucion acuosa catartica.

Country Status (9)

Country Link
US (1) US4975286A (es)
EP (1) EP0298655B1 (es)
JP (1) JP2774106B2 (es)
AT (1) ATE75141T1 (es)
CA (1) CA1326454C (es)
DE (1) DE3870335D1 (es)
ES (1) ES2035292T3 (es)
GR (1) GR3004897T3 (es)
IL (1) IL86859A (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6447763B1 (en) * 1998-06-12 2002-09-10 Ian L. Gordon Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US6946149B2 (en) * 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US6996500B2 (en) * 2002-10-30 2006-02-07 Hewlett-Packard Development Company, L.P. Method for communicating diagnostic data
US7049319B2 (en) * 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
US20050100637A1 (en) * 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
WO2005061008A1 (en) * 2003-12-01 2005-07-07 The United States Of America As Represented By The Secretary Of The Navy Bowel preparation for virtual colonscopy
US8435590B2 (en) * 2008-11-24 2013-05-07 Stokely-Van Camp, Inc. Use of novel carbohydrates and carbohydrate blends to provide a sports beverage with increased absorption
SG187713A1 (en) 2010-08-04 2013-03-28 Borody Thomas J Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
JP6121334B2 (ja) 2010-12-13 2017-04-26 サリックス ファーマシューティカルズ，インコーポレイテッド 胃および結腸製剤ならびにそれらを作製するための方法および使用するための方法
JP5870119B2 (ja) 2011-01-28 2016-02-24 ブレインツリー ラボラトリーズ、インク． 腸洗浄のための、方法、組成物、およびパッケージ
ES2636439T3 (es) 2011-03-09 2017-10-05 Regents Of The University Of Minnesota Composiciones y métodos para el trasplante de microbiota de colon
RU2473330C1 (ru) * 2011-12-09 2013-01-27 Александр Павлович Погромов Средство для кишечного лаважа
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
NZ704014A (en) 2012-07-27 2017-10-27 Redhill Biopharma Ltd Formulations and methods of manufacturing formulations for use in colonic evacuation
RS59667B1 (sr) 2013-03-15 2020-01-31 Braintree Laboratories Inc Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe
KR102561989B1 (ko) 2015-05-14 2023-07-31 핀치 테라퓨틱스 홀딩스 엘엘씨 대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치
DK3297644T3 (da) 2015-05-22 2022-04-11 Univ Arizona State Fremgangsmåder til behandling af autismespektrumforstyrrelse og forbundne symptomer
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
CN110831606A (zh) 2017-04-05 2020-02-21 克雷斯顿沃控股公司 治疗帕金森氏病(pd)和相关疾病的组合物和方法
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
WO2018218159A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
AU2018313766A1 (en) 2017-08-07 2020-02-20 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
WO2020069280A1 (en) 2018-09-27 2020-04-02 Crestovo Holdings Llc Compositions and methods for treating epilepsy and related disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993751A (en) * 1972-11-27 1976-11-23 Cybersol, Inc. Process for stabilizing therapeutic compositions and article
GB8512345D0 (en) * 1985-05-15 1985-06-19 Scras Anti-diarrhea compositions
WO1987000754A1 (en) * 1985-08-01 1987-02-12 Braintree Laboratories, Inc. Low-sodium laxative and lavage formulation

Also Published As

Publication number Publication date
EP0298655A2 (en) 1989-01-11
EP0298655A3 (en) 1989-03-08
US4975286A (en) 1990-12-04
CA1326454C (en) 1994-01-25
JPS6431724A (en) 1989-02-02
DE3870335D1 (de) 1992-05-27
GR3004897T3 (es) 1993-04-28
ATE75141T1 (de) 1992-05-15
EP0298655B1 (en) 1992-04-22
JP2774106B2 (ja) 1998-07-09
IL86859A0 (en) 1988-11-30
IL86859A (en) 1991-12-15

Similar Documents

Publication Publication Date Title
ES2035292T3 (es) Solucion acuosa catartica.
AU4722785A (en) Initiating reperfusion treatment when heart attack symptoms are present
DE3855120D1 (de) The use of AICA riboside or AICA ribotide for the preparation of a medicament against heart attack or stroke in patients with atherosclerosis
UY25374A1 (es) Composiciones de apomorfina útiles en el tratamiento de disfunción sexual femenina
IT1154319B (it) Analizzatore di anidride carbonica nel flusso espiratorio finale per determinare la pressione parziale dell'anidride carbonica nel sangue arterioso di un paziente
DE69432607D1 (de) Inhalierbares kontrastmittel
DK1123094T3 (da) Terapeutiske præparater (II)
FI103376B1 (fi) Laite potilaan sydämen tilavuusvirran parantamiseksi
DK275488D0 (da) Indolonderivater
IT1229568B (it) Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
SE8506029L (sv) Hjert-lungsystem avsett for syresettning av en patients blod
EA200000686A1 (ru) Препараты левозимендана, предназначенные для введения через слизистую оболочку
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
FR2604900B1 (fr) Solution physiologique pour le lavage des parties du corps humain ayant ete mises en contact avec un acide fluorhydrique et concentre pour sa preparation
IT7951184A0 (it) Procedimento per l'elettrolisi di una soluzione acquosa di cloruro alcalino
GR3029357T3 (en) Method of preparing a radioactive rhenium complex solution.
CY1108251T1 (el) Υγρο για αιμοκαθαρση
FR2602677B1 (fr) Solution physiologique pour le lavage des parties du corps humain ou animal ayant ete mises en contact avec un acide ou une base, et concentre pour sa preparation
SU1168252A1 (ru) Способ лечени больных псориазом
FR2602261B1 (fr) Batiment destine a l'entrainement de personnes au port de masques respiratoires
ATE6317T1 (de) Vorrichtung zur einschlafhilfe eines kleinkindes.
UA30945A (uk) Спосіб лікування вірусної інфекції шкіри та слизових оболонок
Wenzel et al. An acute experimental septicemia infection in mice caused by Sphaerophorus(Fusobacterium) necrophorus.
RU93034430A (ru) Способ лечения негнойных заболеваний уха
ITMI931777A1 (it) Agenti per l'ossigenazione extracorporea del sangue

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 298655

Country of ref document: ES